Suchergebnisse - "Ma, Fei"

PubPharm (53)

1

PP2A as a potential therapeutic target for breast cancer : Current insights and future perspectives

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Qi, Y. | Li, L. | Wei, Y. | +1

2

Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer : A systematic review and meta-analysis

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2023

von Li, L. | Zhang, D. | Wu, Y. | +2

3

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer

enthalten in: Military Medical Research | 2023

von Li, Y. | Sun, F. | Li, C. | +6

CommentIn: Mil Med Res. 2023 Sep 12;10(1):42. - PMID 37700352

4

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer

enthalten in: Military medical research | 2023

von Li, Y. | Sun, F. | Li, C. | +6

5

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer

enthalten in: Military medical research | 2023

von Li, Y. | Sun, F. | Li, C. | +6

6

Development of Tumor Markers for Breast Cancer Immunotherapy

enthalten in: Current molecular medicine | 2023

von Fang, Q. | Shen, G. | Xie, Q. | +7

7

Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers

enthalten in: European journal of medicinal chemistry | 2023

von Wen, T. | Wang, J. | Lu, R. | +11

8

Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel

enthalten in: Cell & bioscience | 2023

von Zhang, J. | Guo, F. | Li, C. | +7

9

Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel

enthalten in: Cell & bioscience | 2023

von Zhang, J. | Guo, F. | Li, C. | +7

10

HER2-low breast cancer : Novel detections and treatment advances

enthalten in: Critical reviews in oncology/hematology | 2023

von Wu, Y. | Zhong, R. | Ma, F.

1
2
3
4
5
6
Nächster »
[6]